Clinical Observation of Severe Bronchial Asthma Treated by aerosol inhalation of Pulmicort Respules combined with urbason
10.3760/cma.j.issn.1008-6706.2012.08.025
- VernacularTitle:布地奈德雾化吸入联合甲泼尼龙治疗重症支气管哮喘
- Author:
Wei LI
- Publication Type:Journal Article
- Keywords:
Asthma;
Pulmicort respules;
Urbason
- From:
Chinese Journal of Primary Medicine and Pharmacy
2012;(8):1166-1167
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the efficacy of aerosol inhalation of Pulmicort Respules combined with urbason in treating severe bronchial asthma.MethodsThe clinical data of 40 cases aith severe bronchial asthma treated in our hospital were analyzed retrospectively,among which 20 cases underwent Pulmicort Respules combined with urbason(Tset Group),20 cases underwent urbason( Control Group).ResultsCompared with the control group,the blood gas analysis in test group had statistically significant difference before treatment (P < 0.05 ).Compared with the control group,the clinical effect and the blood gas analysis in test group had no statistically significant difference after treatment(P > 0.05 ).Compared with the control group,the complications in test group had statistically significant difference( P < 0.05),the complications in test group was less than the control group.ConclusionAerosol inhalation of Pulmicort Respules can reduce the amount of urbason and lower the incidence d complications.The combination treatment of this two drugs can achieve the same clinical results alike the clinical effect of large doses of methy lprednisolone.